
New hepatitis C medications are allowing people to receive a kidney transplant from a deceased donor who had the liver disease — a strategy aimed at getting more lifesaving organs to patients languishing on waitlists. Two new studies are highlighting the promise of the approach, showing that if patients are given the drug Mavyret, they… read on >